BioLASCO Taiwan Co., Ltd. (TPEX:6662)
28.05
+1.45 (5.45%)
Nov 20, 2026, 12:53 PM CST
BioLASCO Taiwan Market Cap
BioLASCO Taiwan has a market cap or net worth of 718.42 million as of November 20, 2026. It is the 35,697th most valuable company in the world and the 2,119th biggest in Taiwan. Its market cap has decreased by 10.53% in one year.
Market Cap
718.42M
Enterprise Value
675.30M
Revenue
266.56M
Global Rank
Country Rank
#2,119 Taiwan
PE Ratio
16.12
ChartMarket Cap Chart
Since January 4, 2018, BioLASCO Taiwan's market cap has decreased from 1.58B to 718.42M, a decrease of -54.56%. That is a compound annual growth rate of -8.50%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 718.42M | -9.52% |
| Dec 31, 2025 | 793.97M | -6.34% |
| Dec 31, 2024 | 847.76M | -0.30% |
| Dec 29, 2023 | 850.32M | 11.22% |
| Dec 30, 2022 | 764.52M | -1.97% |
| Dec 30, 2021 | 779.89M | -13.74% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Jan 4, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Level Biotechnology | 921.66M |
| BiOptic | 866.92M |
| TCI GENE | 859.90M |
| Lukas Biomedical | 789.33M |
| Holy Stone Healthcare | 759.06M |
| GeneReach Biotechnology | 693.67M |
| Meribank Biotech | 671.83M |
| NatureWise Biotech & Medicals | 656.59M |